NCT00143416 - Long Term Study With B2036-PEG | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

July 31, 2007

Conditions

Acromegaly

Interventions

DRUG

Pegvisomant

Trial Locations (8)

Pfizer Investigational Site, Kobe

Pfizer Investigational Site, Kozukue-cho, Kouhoku-ku, Yokohama-shi

Pfizer Investigational Site, Kyoto

Pfizer Investigational Site, Hamamatsu

Pfizer Investigational Site, Bonkyo-ku

Pfizer Investigational Site, Shinjuku-ku

Pfizer Investigational Site, Gakuhara, Kishiwada, Osaka

Pfizer Investigational Site, Sannomaru-cho, Naka-ku, Nagoya-shi